Sökning: WFRF:(Plucinski Mateusz M.) > (2019) > Competing risk even...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 18809naa a2201741 4500 | |
001 | oai:DiVA.org:uu-391014 | |
003 | SwePub | |
008 | 190821s2019 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:141340901 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3910142 URI |
024 | 7 | a https://doi.org/10.1186/s12936-019-2837-42 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1413409012 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Dahal, Prabinu World Wide Antimalarial Resistance Network WWARN, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, WorldWide Antimalarial Resistance Network WWARN, Oxford, England4 aut |
245 | 1 0 | a Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria :b a WorldWide Antimalarial Resistance Network individual participant data meta-analysis |
264 | c 2019-07-05 | |
264 | 1 | b BMC,c 2019 |
338 | a electronic2 rdacarrier | |
520 | a Background: Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potentially preclude/pre-empt the detection of subsequent recrudescence of persistent, sub-microscopic primary infections.Methods: Antimalarial studies typically report the risk of recrudescence derived using the Kaplan-Meier (K-M) method, which considers new infections acquired during the follow-up period as censored. Cumulative Incidence Function (CIF) provides an alternative approach for handling new infections, which accounts for them as a competing risk event. The complement of the estimate derived using the K-M method (1 minus K-M), and the CIF were used to derive the risk of recrudescence at the end of the follow-up period using data from studies collated in the WorldWide Antimalarial Resistance Network data repository. Absolute differences in the failure estimates derived using these two methods were quantified. In comparative studies, the equality of two K-M curves was assessed using the log-rank test, and the equality of CIFs using Gray's k-sample test (both at 5% level of significance). Two different regression modelling strategies for recrudescence were considered: cause-specific Cox model and Fine and Gray's sub-distributional hazard model.Results: Data were available from 92 studies (233 treatment arms, 31,379 patients) conducted between 1996 and 2014. At the end of follow-up, the median absolute overestimation in the estimated risk of cumulative recrudescence by using 1 minus K-M approach was 0.04% (interquartile range (IQR): 0.00-0.27%, Range: 0.00-3.60%). The overestimation was correlated positively with the proportion of patients with recrudescence [Pearson's correlation coefficient (rho): 0.38, 95% Confidence Interval (CI) 0.30-0.46] or new infection [rho: 0.43; 95% CI 0.35-0.54]. In three study arms, the point estimates of failure were greater than 10% (the WHO threshold for withdrawing antimalarials) when the K-M method was used, but remained below 10% when using the CIF approach, but the 95% confidence interval included this threshold.Conclusions: The 1 minus K-M method resulted in a marginal overestimation of recrudescence that became increasingly pronounced as antimalarial efficacy declined, particularly when the observed proportion of new infection was high. The CIF approach provides an alternative approach for derivation of failure estimates in antimalarial trials, particularly in high transmission settings. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng |
653 | a Plasmodium falciparum | |
653 | a Treatment efficacy study | |
653 | a Competing risk event | |
700 | 1 | a Simpson, Julie Anneu Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostatist, Melbourne, Vic, Australia4 aut |
700 | 1 | a Abdulla, Salimu Ifakara Hlth Inst, Dar Es Salaam, Tanzania4 aut |
700 | 1 | a Achan, Janeu MRC Unit, Banjul, Gambia4 aut |
700 | 1 | a Adam, Ishagu Univ Khartoum, Fac Med, Khartoum, Sudan4 aut |
700 | 1 | a Agarwal, Aartiu Karolinska Institutet4 aut |
700 | 1 | a Allan, Richardu Mentor Initiat, Fajara, Gambia4 aut |
700 | 1 | a Anvikar, Anupkumar R.u Natl Inst Malaria Res, Sector 8, Dwarka, New Delhi 110077, India4 aut |
700 | 1 | a Arinaitwe, Emmanuelu Infect Dis Res Collaborat, Kampala, Uganda4 aut |
700 | 1 | a Ashley, Elizabeth A.u Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England;Myanmar Oxford Clin Res Unit, Yangon, Myanmar4 aut |
700 | 1 | a Awab, Ghulam Rahimu Mahidol Univ, Fac Trop Med, Bangkok, Thailand;Minist Publ Hlth, Islam Republ Afghanistan, Kabul, Afghanistan4 aut |
700 | 1 | a Bassat, Quiqueu Ctr Investigacao Saude Manhica CISM, Maputo, Mozambique;Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain;ICREA, Pg Lluis Companys 23, Barcelona 08010, Spain4 aut |
700 | 1 | a Bjorkman, Andersu Karolinska Inst, Depatment Microbiol Tumour & Cell Biol, Stockholm, Sweden4 aut |
700 | 1 | a Bompart, Francoisu Sanofi Access Med, Gentilly, France4 aut |
700 | 1 | a Borrmann, Steffenu Kenya Med Res Inst Kilifi, Kilifi, Kenya;Wellcome Trust Res Programme, Kilifi, Kenya;Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany4 aut |
700 | 1 | a Bousema, Teunu Radboud Inst Hlth Sci, Radboudumc Nijmegen, Nijmegen, Netherlands;Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands4 aut |
700 | 1 | a Broek, Ingridu Centrum Infectieziektebestrijding, Epidemioloog Epidemiol Surveillance RIVM, Bilthoven, Netherlands4 aut |
700 | 1 | a Bukirwa, Hasifau African Field Epidemiol Network, Kampala, Uganda4 aut |
700 | 1 | a Carrara, Verena I.u Shoklo Malaria Res Unit, Mae Sot, Bangkok, Thailand;Mahidol Oxford Univ Res Unit, Bangkok, Thailand4 aut |
700 | 1 | a Corsi, Marcou Private Consultancy Drug Dev Trop Dis, Sigma Tau SpA Ind Farmaceutiche Riunite, Pomezia, Rome, Italy4 aut |
700 | 1 | a Cot, Michelu Univ Paris 05, Sorbonne Paris Cite, MERIT, IRD, F-75006 Paris, France4 aut |
700 | 1 | a D'Alessandro, Umbertou MRC Unit, Fajara, Gambia;London Sch Hyg & Trop Med, London, England4 aut |
700 | 1 | a Davis, Timothy M. E.u Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia4 aut |
700 | 1 | a de Wit, Maritu Med Sans Frontieres Operat Ctr Amsterdam, Geneva, Switzerland4 aut |
700 | 1 | a Deloron, Philippeu Univ Paris 05, Sorbonne Paris Cite, MERIT, IRD, F-75006 Paris, France4 aut |
700 | 1 | a Desai, Meghnau Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA4 aut |
700 | 1 | a Dimbu, Pedro Rafaelu Natl Malaria Control Program, Luanda, Angola4 aut |
700 | 1 | a Djalle, Djibrineu Inst Pasteur, BP 923, Bangui, Cent Afr Republ4 aut |
700 | 1 | a Djimde, Abdoulayeu Univ Sci Techn & Technol Bamako, Fac Pharm, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Bamako, Mali4 aut |
700 | 1 | a Dorsey, Grantu Univ Calif San Francisco, Dept Med, San Francisco, CA USA4 aut |
700 | 1 | a Doumbo, Ogobara K.u Univ Sci Techn & Technol Bamako, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med & Odonto Stomatol, Bamako, Mali4 aut |
700 | 1 | a Drakeley, Chris J.u London Sch Hyg & Trop Med, Dept Infect & Immun, London, England4 aut |
700 | 1 | a Duparc, Stephanu Med Malaria Venture, Geneva, Switzerland4 aut |
700 | 1 | a Edstein, Michael D.u Australian Army Malaria Inst, Brisbane, Qld, Australia4 aut |
700 | 1 | a Espie, Emmanuelleu R&D Ctr, GSK Vaccines, Clin & Epidemiol Dept, Epicentre, Ave Fleming 20,1300 Wavre,8 Rue St Sabin, F-75011 Paris, France4 aut |
700 | 1 | a Faiz, Abulu Malaria Res Grp, Chittagong, Bangladesh;Dev Care Fdn, Dhaka, Bangladesh4 aut |
700 | 1 | a Falade, Catherineu Univ Ibadan, Coll Med, Dept Pharmacol & Therapeut, Ibadan, Nigeria4 aut |
700 | 1 | a Fanello, Caterinau Univ Oxford, Nuffield Dept Med, Ctr Global Hlth, Oxford, England4 aut |
700 | 1 | a Faucher, Jean-Francoisu Besancon Univ Med Ctr, Dept Infect Dis, Mother & Child Hlth Trop Res Unit, Inst Rech Dev IRD, Besancon, France4 aut |
700 | 1 | a Faye, Babacaru Univ Cheikh Anta Diop, Fac Med, Dept Med Parasitol, Dakar, Senegal4 aut |
700 | 1 | a Fortes, Filomeno de Jesusu Natl Malaria Control Program, Luanda, Angola4 aut |
700 | 1 | a Gadalla, Nahla B.u Sudanese Amer Med Assoc, Fairfax, VA USA4 aut |
700 | 1 | a Gaye, Oumaru Univ Cheikh Anta Diop, Dept Med Parasitol, Fac Med, Dakar, Senegal4 aut |
700 | 1 | a Gil, J. Pedrou Karolinska Institutet4 aut |
700 | 1 | a Greenwood, Brianu London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England4 aut |
700 | 1 | a Grivoyannis, Anastasiau Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA4 aut |
700 | 1 | a Hamed, Kamalu Basilea Pharmaceut Int Ltd, Basel, Switzerland;Novartis Pharmaceut, E Hanover, NJ USA4 aut |
700 | 1 | a Hien, Tran Tinhu Oxford Univ Clin Res Unit OUCRU, Ctr Trop Med, Wellcome Trust Major Overseas Program MOP, Oxford, England4 aut |
700 | 1 | a Hughes, Davidu Novartis Int AG, Basel, Switzerland4 aut |
700 | 1 | a Humphreys, Georginau Wellcome Trust Res Labs, London, England;World Wide Antimalarial Resistance Network WWARN, London, England4 aut |
700 | 1 | a Hwang, Jimeeu US Centers Dis Control & Prevent, Div Parasit Dis & Malaria, US Presidents Malaria Initiat Malaria Branch, Atlanta, GA USA;Univ Calif San Francisco, San Francisco, CA 94143 USA;Global Hlth Grp, San Francisco, CA 94143 USA4 aut |
700 | 1 | a Ibrahim, Maman Laminouu Ctr Rech Med & Saniataire CERMES, Niamey, Niger4 aut |
700 | 1 | a Janssens, Bartu Medecins Sans Frontieres, Phnom Penh, Belgium4 aut |
700 | 1 | a Jullien, Vincentu Univ Paris 05, Assistance Publique Hop Paris, Serv Pharmacol Clin, Paris, France;Grp Hosp Cochin Saint Vincent Paul, Inserm U663, WWARN, Paris, France4 aut |
700 | 1 | a Juma, Elizabethu Kenya Govt Med Res Ctr, Nairobi, Kenya4 aut |
700 | 1 | a Kamugisha, Erasmusu Weill Bugando Univ Coll Hlth Sci, Mwanza, Tanzania4 aut |
700 | 1 | a Karema, Corineu Minist Hlth, Natl Malaria Control Program TRAC Plus, Kigali, Rwanda4 aut |
700 | 1 | a Karunajeewa, Harin A.u Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia4 aut |
700 | 1 | a Kiechel, Jean R.u Drugs Neglected Dis initiat, Geneva, Switzerland4 aut |
700 | 1 | a Kironde, Fredu Islam Univ Uganda, Habib Med Sch, Kampala, Uganda4 aut |
700 | 1 | a Kofoed, Poul-Eriku Bandim Hlth Project, Indepth Network, Apartado 861, Bissau, Guinea Bissau;Lillebaelt Hosp, Hlth Serv Res Unit, Vejle, Denmark;IRS Univ Southern Denmark, Vejle, Denmark;Kolding Cty Hosp, Dept Paediat, Kolding, Denmark4 aut |
700 | 1 | a Kremsner, Peter G.u Univ Tubingen, Inst Trop Med, Tubingen, Germany;Ctr Recherches Medic Lambarene, Lambarene, Gabon4 aut |
700 | 1 | a Lameyre, Valerieu Sanofi Access Med, Gentilly, France4 aut |
700 | 1 | a Lee, Sue J.u Mahidol Univ, Fac Trop Med, Bangkok, Thailand;Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England4 aut |
700 | 1 | a Marsh, Kevinu Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England;Wellcome Trust Res Programme, Kilifi, Kenya;Kenya Govt Med Res Ctr, Kilifi, Kenya4 aut |
700 | 1 | a Mårtensson, Andreas,d 1963-u Uppsala universitet,Internationell barnhälsa och nutrition4 aut0 (Swepub:uu)andma331 |
700 | 1 | a Mayxay, Mayfongu Mahosot Hosp, Lao Oxford Mahosot Hospital, Wellcome Trust Res Unit, Microbiol Lab, Viangchan, Laos4 aut |
700 | 1 | a Menan, Herveu Univ Cocody, Dept Parasitol, Fac Pharm, Abidjan, Cote Ivoire;Univ Hlth Sci, Minist Hlth, Fac Postgraduate Studies, Viangchan, Laos4 aut |
700 | 1 | a Mens, Petrau Acad Med Ctr, Med Microbiol Parasitol, Amsterdam, Netherlands4 aut |
700 | 1 | a Mutabingwa, Theonest K.u Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania;London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England4 aut |
700 | 1 | a Ndiaye, Jean-Louisu Univ Cheikh Anta Diop, Fac Med, Parasitol & Mycol Lab, Dakar, Senegal4 aut |
700 | 1 | a Ngasala, Billy E.u Muhimbili Univ Hlth & Allied Sci, Dept Parasitol, Dar Es Salaam, Tanzania;Karolinska Inst, Dept Med Solna, Infect Dis Unit, Malaria Res, Stockholm, Sweden4 aut |
700 | 1 | a Noedl, Haraldu Med Univ Vienna, Vienna, Austria4 aut |
700 | 1 | a Nosten, Francoisu Univ Oxford, Nuffield Dept Med Res Bldg, Ctr Trop Med & Global Hlth, Old Rd Campus, Oxford, England;Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand4 aut |
700 | 1 | a Offianan, Andre Toureu Inst Pasteur Cote Ivoire, Malariol Dept, Abidjan, Cote Ivoire4 aut |
700 | 1 | a Oguike, Maryu London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England4 aut |
700 | 1 | a Ogutu, Bernhards R.u Kenya Govt Med Res Ctr, Kisumu, Kenya;US Army Med Res Unit, Kisumu, Kenya4 aut |
700 | 1 | a Olliaro, Pierou UNICEF, UNDP, World Bank, WHO TDR, Geneva, Switzerland4 aut |
700 | 1 | a Ouedraogo, Jean Boscou Inst Rech Sci Sante, Direct Regionale Ouest, Bobo Dioulasso, Burkina Faso;Ctr Muraz Bobo Dioulasso, Non Transmissible Dis Dept, Bobo Dioulasso, Burkina Faso4 aut |
700 | 1 | a Piola, Patriceu Inst Pasteur Cambodge, Phnom Penh, Cambodia4 aut |
700 | 1 | a Plowe, Christopher V.u Duke Univ, Duke Global Hlth Inst, Durham, NC USA4 aut |
700 | 1 | a Plucinski, Mateusz M.u US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, US Presidents Malaria Initiat, Atlanta, GA USA;Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA4 aut |
700 | 1 | a Pratt, Oliver Jamesu Minist Hlth & Social Welf, Natl Malaria Control Program, Monrovia, Liberia4 aut |
700 | 1 | a Premji, Zulfikaraliu Muhimbili Univ Coll Hlth Sci, Dar Es Salaam, Tanzania4 aut |
700 | 1 | a Ramharter, Michaelu Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany4 aut |
700 | 1 | a Rogier, Christopheu Div Expertise & Def Hlth strategy, Cent Directorate, French Mil Hlth Serv, Paris, France;IRBA, Bretigny Sur Orge, France;URMITE, UMR 6236, Marseille, France4 aut |
700 | 1 | a Rombo, Larsu Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)4 aut0 (Swepub:uu)larra728 |
700 | 1 | a Rosenthal, Philip J.u Univ Calif San Francisco, Dept Med, San Francisco, CA USA4 aut |
700 | 1 | a Sawa, Patricku Human Hlth Div, Int Ctr Insect Physiol & Ecol, Mbita, Kenya4 aut |
700 | 1 | a Schramm, Birgitu Epicentre, Paris, France4 aut |
700 | 1 | a Sibley, Carolu WWARN, Oxford, England;Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA4 aut |
700 | 1 | a Sinou, Veroniqueu Aix Marseille Univ, INSERM, SSA, IRBA,MCT, Marseille, France4 aut |
700 | 1 | a Sirima, Sodiomonu GRAS, 06 BP 10248, Ouagadougou 06, Burkina Faso4 aut |
700 | 1 | a Smithuis, Franku Myanmar Oxford Clin Res Unit, Oxford, England4 aut |
700 | 1 | a Staedke, Sarah G.u Infect Dis Res Collaborat, Kampala, Uganda;London Sch Hyg & Trop Med, Dept Clin Res, London, England4 aut |
700 | 1 | a Sutanto, Ingeu Univ Indonesia, Dept Parasitol, Fac Med, 6 Salemba Raya, Jakarta 10430, Indonesia4 aut |
700 | 1 | a Talisuna, Ambrose Otauu WHO, Reg Off Afr, Brazzaville, Rep Congo;Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England4 aut |
700 | 1 | a Tarning, Joelu WorldWide Antimalarial Resistance Network, Oxford, England;Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand4 aut |
700 | 1 | a Taylor, Walter R. J.u Mahidol Univ, Fac Trop Med, Bangkok, Thailand4 aut |
700 | 1 | a Temu, Emmanuelu MENTOR Initiat, Crawley, England4 aut |
700 | 1 | a Thriemer, Kamala L.u Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia4 aut |
700 | 1 | a Thuy, Nhien Nguyenu Oxford Univ Clin Res Unit OUCRU, Wellcome Trust Major Overseas Program MOP, Ctr Trop Med, Oxford, England4 aut |
700 | 1 | a Udhayakumar, Venkatachalamu Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch & Presidents Malaria Initiat, Atlanta, GA USA4 aut |
700 | 1 | a Ursing, Johanu Karolinska Institutet4 aut |
700 | 1 | a van Herp, Michelu Operat Ctr Brussels, Med Sans Frontieres, Brussels, Belgium;Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands4 aut |
700 | 1 | a van Vugt, Michele4 aut |
700 | 1 | a Whitty, Christopheru London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Malaria Partnership, London, England4 aut |
700 | 1 | a William, Yavou Univ Cocody, Dept Parasitol, Fac Pharm, Abidjan, Cote Ivoire4 aut |
700 | 1 | a Winnips, Cornelisu NovartisInternat AG, Basel, Switzerland4 aut |
700 | 1 | a Zongo, Issakau Inst Rech Sci Sante, Direct Regionale lOuest, Bobo Dioulasso, Burkina Faso4 aut |
700 | 1 | a Guerin, Philippeu World Wide Antimalarial Resistance Network WWARN, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England4 aut |
700 | 1 | a Price, Ric N.u World Wide Antimalarial Resistance Network WWARN, Oxford, England;Menzies Sch Hlth Res Charles Darwin Univ, Darwin, NT, Australia;Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England4 aut |
700 | 1 | a Stepniewska, Kasiau World Wide Antimalarial Resistance Network WWARN, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, WorldWide Antimalarial Resistance Network WWARN, Oxford, England4 aut |
710 | 2 | a World Wide Antimalarial Resistance Network WWARN, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England;Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, WorldWide Antimalarial Resistance Network WWARN, Oxford, Englandb Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostatist, Melbourne, Vic, Australia4 org |
773 | 0 | t Malaria Journald : BMCg 18q 18x 1475-2875 |
856 | 4 | u https://doi.org/10.1186/s12936-019-2837-4y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1344476/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-019-2837-4 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-391014 |
856 | 4 8 | u https://doi.org/10.1186/s12936-019-2837-4 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:141340901 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy